Natco Pharma Limited: Rights Issue
Rights Issue - Natco Pharma Limited has informed the Exchange that Board of Directors at its meeting held on September 25, 2026, has decided to issue equity shares on rights basis in the ratio of 2 : 21, i.e 2 Equity Shares for every 21 Equity Shares held at an Issue Price of Rs. 750 per share (including a premium of ₹ 748/- (Rupees Seven Hundred and Forty Eight only) per Rights Equity Share)
SectorPharma & Healthcare
Value₹750
Sources
- NSE filing - Natco Pharma Limited · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026